David Blecken
Oct 17, 2008

Boehringer Ingelheim selects Vizeum in China

SHANGHAI - German pharmaceutical giant Boehringer Ingelheim has picked Vizeum China to handle media duties for its Mucosolvan cough remedy, following a review that also included incumbent MediaCom and Hakuhodo.

Boehringer Ingelheim selects Vizeum in China
Vizeum will reportedly develop a range of materials and initiatives for the brand, including point-of-sale promotions, advertorials, healthcare booklets, trade communications and community events. The Aegis Group agency restructured as a full-service operation earlier this year.

As the world’s leading expectorant, Mucosolvan positions itself as a remedy that enables mothers to care for their families.

Source:
Campaign China

Related Articles

Just Published

5 hours ago

Not a masterpiece but Skyn's V-Day ad ditches ...

EXCLUSIVE: Skyn lands precious konbini shelf space in Japan’s cutthroat convenience store market. The brand announces that with a cheeky spot and an empowered protagonist.

6 hours ago

Trump's tariffs: What will happen to Chinese ...

With uncertainty looming over Chinese outbound brands that face steep tariffs in the US, Campaign asks brand experts how Chinese brands should sustain their growth and relevance overseas.

7 hours ago

Kunal Jeswani appointed CEO of Ogilvy ASEAN

Jeswani, who is also CEO of Ogilvy Singapore and Malaysia, will take on additional duties as ASEAN CEO, a newly created role focusing on growth in this important sub-region.

7 hours ago

Moves and wins roundup: Week of February 3, 2025

P&G, Cheil, HP, Wavemaker, AW, and more in our weekly collection of people moves and account news.